West Pharmaceutical Services (WST) Competitors

$375.46
+3.42 (+0.92%)
(As of 04/22/2024 ET)

WST vs. RMD, BAX, SWAV, PODD, TFX, PEN, GMED, DXCM, BDX, and BSX

Should you be buying West Pharmaceutical Services stock or one of its competitors? The main competitors of West Pharmaceutical Services include ResMed (RMD), Baxter International (BAX), Shockwave Medical (SWAV), Insulet (PODD), Teleflex (TFX), Penumbra (PEN), Globus Medical (GMED), DexCom (DXCM), Becton, Dickinson and Company (BDX), and Boston Scientific (BSX). These companies are all part of the "surgical & medical instruments" industry.

West Pharmaceutical Services vs.

ResMed (NYSE:RMD) and West Pharmaceutical Services (NYSE:WST) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, community ranking, media sentiment, risk, profitability and institutional ownership.

ResMed currently has a consensus price target of $199.20, suggesting a potential upside of 10.45%. West Pharmaceutical Services has a consensus price target of $435.20, suggesting a potential upside of 15.91%. Given ResMed's stronger consensus rating and higher possible upside, analysts plainly believe West Pharmaceutical Services is more favorable than ResMed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ResMed
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70
West Pharmaceutical Services
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

West Pharmaceutical Services has a net margin of 20.12% compared to West Pharmaceutical Services' net margin of 19.77%. West Pharmaceutical Services' return on equity of 23.86% beat ResMed's return on equity.

Company Net Margins Return on Equity Return on Assets
ResMed19.77% 23.86% 14.78%
West Pharmaceutical Services 20.12%21.60%16.26%

ResMed has a beta of 0.67, suggesting that its stock price is 33% less volatile than the S&P 500. Comparatively, West Pharmaceutical Services has a beta of 1.04, suggesting that its stock price is 4% more volatile than the S&P 500.

ResMed received 150 more outperform votes than West Pharmaceutical Services when rated by MarketBeat users. However, 55.74% of users gave West Pharmaceutical Services an outperform vote while only 52.82% of users gave ResMed an outperform vote.

CompanyUnderperformOutperform
ResMedOutperform Votes
412
52.82%
Underperform Votes
368
47.18%
West Pharmaceutical ServicesOutperform Votes
262
55.74%
Underperform Votes
208
44.26%

55.0% of ResMed shares are held by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are held by institutional investors. 1.2% of ResMed shares are held by insiders. Comparatively, 0.5% of West Pharmaceutical Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

ResMed has higher revenue and earnings than West Pharmaceutical Services. ResMed is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ResMed$4.22B6.28$897.56M$6.0529.81
West Pharmaceutical Services$2.95B9.32$593.40M$7.8847.65

In the previous week, West Pharmaceutical Services had 10 more articles in the media than ResMed. MarketBeat recorded 22 mentions for West Pharmaceutical Services and 12 mentions for ResMed. West Pharmaceutical Services' average media sentiment score of 0.73 beat ResMed's score of 0.63 indicating that ResMed is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ResMed
6 Very Positive mention(s)
0 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
West Pharmaceutical Services
10 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

ResMed pays an annual dividend of $1.92 per share and has a dividend yield of 1.1%. West Pharmaceutical Services pays an annual dividend of $0.80 per share and has a dividend yield of 0.2%. ResMed pays out 31.7% of its earnings in the form of a dividend. West Pharmaceutical Services pays out 10.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. ResMed has raised its dividend for 12 consecutive years and West Pharmaceutical Services has raised its dividend for 1 consecutive years. ResMed is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

West Pharmaceutical Services beats ResMed on 12 of the 21 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WST vs. The Competition

MetricWest Pharmaceutical ServicesSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$27.24B$3.73B$4.74B$17.23B
Dividend Yield0.22%2.18%5.47%3.58%
P/E Ratio47.6511.62186.9021.51
Price / Sales9.3255.392,465.6810.07
Price / Cash36.5543.1631.5714.84
Price / Book9.554.244.554.95
Net Income$593.40M$4.20M$101.19M$964.12M
7 Day Performance-1.06%-1.36%-1.35%0.72%
1 Month Performance-4.69%-6.46%-6.69%-3.11%
1 Year Performance2.62%13.13%8.23%94.37%

West Pharmaceutical Services Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RMD
ResMed
4.8359 of 5 stars
$184.85
-0.1%
$199.20
+7.8%
-20.9%$27.19B$4.22B30.5510,140Upcoming Earnings
BAX
Baxter International
4.927 of 5 stars
$39.56
-1.2%
$46.30
+17.0%
-10.8%$20.09B$14.81B7.5860,000
SWAV
Shockwave Medical
4.3559 of 5 stars
$327.50
+0.1%
$309.11
-5.6%
+14.7%$12.25B$730.23M84.631,468Positive News
PODD
Insulet
4.6983 of 5 stars
$172.71
-0.7%
$250.33
+44.9%
-48.5%$12.09B$1.70B59.353,000Positive News
TFX
Teleflex
4.8108 of 5 stars
$210.18
-0.2%
$265.56
+26.3%
-23.0%$9.90B$2.97B27.9114,500Positive News
PEN
Penumbra
4.9361 of 5 stars
$210.07
-0.1%
$304.45
+44.9%
-27.5%$8.13B$1.06B90.944,200Positive News
GMED
Globus Medical
4.748 of 5 stars
$51.79
-0.1%
$66.33
+28.1%
-11.5%$7.01B$1.02B44.275,000
DXCM
DexCom
4.3802 of 5 stars
$136.52
+1.5%
$141.40
+3.6%
+6.3%$52.63B$3.62B104.219,600Upcoming Earnings
BDX
Becton, Dickinson and Company
4.7612 of 5 stars
$231.01
-1.6%
$280.00
+21.2%
-10.5%$66.74B$19.37B54.7473,000
BSX
Boston Scientific
4.3306 of 5 stars
$68.11
+1.0%
$68.50
+0.6%
+33.1%$99.92B$14.24B63.6548,000Upcoming Earnings
Options Volume

Related Companies and Tools

This page (NYSE:WST) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners